Allogene Therapeutics
ALLO
$2.97
Share price
1.71%
Change (1 day)
-44.49%
Change (1 year)
Categories
EPS for Allogene Therapeutics (ALLO)
EPS in 2023 (TTM): -$2.45
According to Allogene Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.45. In 2022 the company made an earnings per share (EPS) of -$2.32 a decrease over its 2021 EPS that were of -$1.89.
EPS history for Allogene Therapeutics from 2018 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.45 | 5.6% |
| 2022 | -$2.32 | 22.75% |
| 2021 | -$1.89 | -9.13% |
| 2020 | -$2.08 | 14.92% |
| 2019 | -$1.81 | -9.42% |
| 2018 | -$2.00 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -11.02% | 🇺🇸 USA |